SIRT6 activator MDL-800 alleviates periodontal inflammation by inhibiting AIM2 pathway.

Researchers found that MDL-800, a SIRT6 activator, reduced bone loss and inflammation in periodontitis models by suppressing the AIM2 inflammatory pathway, suggesting potential as a treatment to improve periodontal disease outcomes.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.